Aug 31, 2022 05:38 PM (GMT+8) · EqualOcean
MSD (Chinese: 默沙东) announced that a new indication for its Human Papillomavirus 9-valent Vaccine, also known as Gardasil 9, has been approved by China’s National Medical Products Administration (NMPA) on August 30, which means that Chinese women aged from 9 to 45 years old can receive MSD’s Gardasil 9 starting from August 31, 2022. Previously, MSD’s 9-valent Vaccine was approved in China for women aged 16-26 years. For women who are over 26 years old, they can only receive Human Papillomavirus quadrivalent or bivalent Vaccine.

Source: